Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

A history of pharmacoepidemiology.

Bégaud B.

Therapie. 2018 Oct 19. pii: S0040-5957(18)30238-5. doi: 10.1016/j.therap.2018.10.003. [Epub ahead of print]

PMID:
30392701
2.

Pharmacovigilance during the pre-approval phases: an evolving pharmaceutical industry model in response to ICH E2E, CIOMS VI, FDA and EMEA/CHMP risk-management guidelines.

Hartford CG, Petchel KS, Mickail H, Perez-Gutthann S, McHale M, Grana JM, Marquez P.

Drug Saf. 2006;29(8):657-73. Review.

PMID:
16872240
3.

What is pharmacoepidemiology? Definition, methods, interest and clinical applications.

Montastruc JL, Benevent J, Montastruc F, Bagheri H, Despas F, Lapeyre-Mestre M, Sommet A.

Therapie. 2018 Oct 10. pii: S0040-5957(18)30221-X. doi: 10.1016/j.therap.2018.08.001. [Epub ahead of print]

PMID:
30389102
4.

[Pharmacoepidemiology: definition, methods and applications].

Montastruc JL, Sommet A, Montastruc F, Moulis G, Bagheri H, Damase-michel C, Lapeyre-mestre M.

Bull Acad Natl Med. 2015 Feb-Mar;199(2-3):263-73; discussion 273. French.

PMID:
27476308
5.

Role of pharmacoepidemiology in evaluating prescription drug safety in pediatrics.

Luo X, Doherty J, Cappelleri JC, Frush K.

Curr Med Res Opin. 2007 Nov;23(11):2607-15. Review.

PMID:
17854515
6.

From a Viewpoint of Clinical Settings: Pharmacoepidemiology as Reverse Translational Research (rTR).

Kawakami J.

Yakugaku Zasshi. 2017;137(6):681-683. doi: 10.1248/yakushi.16-00250-2. Review. Japanese.

7.

Major advances in international pharmacoepidemiology.

Tilson HH.

Ann Epidemiol. 1990 Dec;1(2):205-12.

PMID:
1669501
8.

Importance of feasibility assessments before implementing non-interventional pharmacoepidemiologic studies of vaccines: lessons learned and recommendations for future studies.

Willame C, Baril L, van den Bosch J, Ferreira GL, Williams R, Rosillon D, Cohet C.

Pharmacoepidemiol Drug Saf. 2016 Dec;25(12):1397-1406. doi: 10.1002/pds.4081. Epub 2016 Sep 7.

9.

[Pharmacoepidemiology: lights and shadows].

Laporte JR, Diogene E.

Bull Acad Natl Med. 2015 Feb-Mar;199(2-3):281-8. French.

PMID:
27476310
10.

A Pharmacoepidemiology Database System for Monitoring Risk Due to the Use of Medicines by New Zealand Primary Care Patients.

Tomlin AM, Reith DM, Woods DJ, Lloyd HS, Smith A, Fountain JS, Tilyard MW.

Drug Saf. 2017 Dec;40(12):1259-1277. doi: 10.1007/s40264-017-0579-1.

PMID:
28766108
11.

Pharmacoepidemiology studies: what levels of evidence and how can they be reached?

Lapeyre-Mestre M, Sapède C, Moore N; participants of round table N° 5 of Giens Workshops XXVIII (th), Bilbault P, Blin P, Chopy D, Evans D, Gueyffier F, Lacoin L, Malbezin M, Micallef J, Morlet-Vigier D, Muller S, Oger E, Plétan Y, Pons G, Verpillat P, Vigneau C.

Therapie. 2013 Jul-Aug;68(4):241-52. doi: 10.2515/therapie/2013038. Epub 2013 Aug 28. English, French.

12.

The intriguing future of pharmacoepidemiology.

Wettermark B.

Eur J Clin Pharmacol. 2013 May;69 Suppl 1:43-51. doi: 10.1007/s00228-013-1496-6. Epub 2013 May 3.

PMID:
23640187
14.

La pharmaco-épidémiologie ou comment évaluer les médicaments dans la vraie vie ?

Bezin J, Bosco-Levy P, Pariente A.

Rev Prat. 2017 Jun;67(6):657-660. French.

PMID:
30512740
15.

[Pharmacoepidemiolgy: regulatory basis, methodological approaches and scope].

Ahid S, Belaguide K, Cherrah Y.

East Mediterr Health J. 2012 Jan;18(1):85-93. Review. French.

PMID:
22360016
16.

Utilization of health care databases for pharmacoepidemiology.

Takahashi Y, Nishida Y, Asai S.

Eur J Clin Pharmacol. 2012 Feb;68(2):123-9. doi: 10.1007/s00228-011-1088-2. Epub 2011 Aug 2. Review.

PMID:
21808989
17.

[Translation and introduction of Guide to Methodological Standards in Pharmacoepidemiology].

Tian F, Liao X, Xie YM.

Zhongguo Zhong Yao Za Zhi. 2013 Sep;38(18):2949-57. Chinese.

PMID:
24471310
18.

An overview of pharmacoepidemiology in New Zealand: medical databases, registries and research achievements.

Nishtala P, Ndukwe H, Chyou TY, Salahudeen M, Narayan S.

N Z Med J. 2017 Jan 27;130(1449):52-61. Review.

PMID:
28178730
19.

Post-approval Studies for Rare Disease Treatments and Orphan Drugs.

Maier WC, Christensen RA, Anderson P.

Adv Exp Med Biol. 2017;1031:197-205. doi: 10.1007/978-3-319-67144-4_11. Review.

PMID:
29214573
20.

Tuberculosis.

Bloom BR, Atun R, Cohen T, Dye C, Fraser H, Gomez GB, Knight G, Murray M, Nardell E, Rubin E, Salomon J, Vassall A, Volchenkov G, White R, Wilson D, Yadav P.

In: Holmes KK, Bertozzi S, Bloom BR, Jha P, editors. Major Infectious Diseases. 3rd edition. Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2017 Nov 3. Chapter 11.

Supplemental Content

Support Center